Ductal Carcinoma In Situ Treatment in Singapore
- Top Accredited Hospitals
- Global Medical Standards
- Cutting-Edge Technology
- Proven Treatment Options
- High Success Rate
- Trusted by Millions
What is Ductal Carcinoma In Situ?
Ductal carcinoma in situ is an extremely early form of breast cancer. When it occurs, the cancer cells are contained within a breast milk duct, and the surrounding breast tissue remains free of cancerous cells. A common term for this type of breast cancer is DCIS. This type of breast cancer is sometimes referred to as stage 0, noninvasive, or preinvasive.
DCIS is usually found on a mammogram that is done to screen for breast cancer or to investigate a lump in the breast. There is a minimal chance that DCIS will become invasive and threaten life. However, it must be evaluated, and treatment options must be considered.
DCIS is often treated with surgery. Other treatments may include hormone therapy or radiation therapy in addition to surgery.
What is the Importance of Timely Treatment?
Ductal Cell Carcinoma in Situ (DCIS) must be treated early to lower the chance of recurrence and spread to other body areas, as well as to stop it from developing into invasive breast cancer. Early detection reduces the psychological and physical effects of more invasive surgeries, increases survival rates, and permits breast-conserving therapy. Patients who receive immediate treatment for DCIS have a better prognosis and a higher quality of life, and their chances of the disease developing into something invasive or life-threatening are significantly decreased.
What are the Common Symptoms of Ductal Carcinoma In situ?
Typically, ductal carcinoma in situ does not exhibit any symptoms. DCIS is another name for this early stage of breast cancer.
DCIS can occasionally result in symptoms like:
- A lump in the breast.
- Bloody discharge from the nipples.
Mammography is typically where DCIS is detected. In breast tissue, it manifests as microscopic calcium particles. These are calcifications, which are deposits of calcium.
Causes and Risk Factors of Ductal Carcinoma In Situ
Causes
- A non-malignant breast cancer that starts in the milk ducts is referred to as ductal carcinoma in situ (DCIS). While their exact cause is not known, risk factors are age (typically greater than 50), radiation, family history or genetic defects (e.g., BRCA1/2), hormonal imbalances, and personal history of benign breast disease.
- The risk can also be increased by lifestyle factors such as obesity, alcohol consumption, and lack of exercise, as well as previous reproductive history. Early detection screening is key to the management of DCIS.
Risk Factors
- Age
- Hormonal Factors
- History & Genetics
- Personal History of Breast Conditions
- Radiation Exposure
- Obesity
Connect with our advisor for a PRIORITY response
Latest Research and Technologies in the Treatment of Ductal Carcinoma In Situ in Singapore
In Singapore, the approach to treating Ductal Carcinoma In Situ (DCIS) has undergone significant evolution, thanks to advancements in technology and enhanced clinical practices. Surgical interventions, including lumpectomy and mastectomy, are still at the forefront of treatment, often accompanied by radiotherapy to help minimise the risk of recurrence. The adoption of oncoplastic surgery techniques enables effective tumour removal while preserving the breast's aesthetic qualities. Furthermore, cutting-edge technologies such as augmented reality microscopes and deep learning-based grading systems are enhancing the precision and reliability of histopathological evaluations. These innovations are focused on personalising treatments, reducing the likelihood of overtreatment, and ultimately improving outcomes for patients.
Treatment options for Ductal Carcinoma In Situ
Lumpectomy: The breast cancer and a portion of the surrounding normal tissue are cut out during a lumpectomy. There is no removal of the rest of the breast tissue. Wide local excision and breast-conserving surgery are alternative names for this procedure. Most patients who have a lumpectomy also undergo radiation therapy.
Mastectomy: The removal of all the breast tissue by operation is called a mastectomy. If you prefer, breast reconstruction to re-form the appearance of the breast may be performed at the same time or later on.
Cost Start From USD 5000 - USD 25000Explore Options
Hormone therapy: Endocrine therapy, also referred to as hormone therapy, involves using drugs that prevent the body from making specific hormones. It is applied in the treatment of breast cancers that are estrogen and progesterone-sensitive.
Cost Start From USD 1000 - USD 3000Explore Options
Radiation Therapy: To reduce the risk of recurrence, radiation therapy is often given after surgery for ductal carcinoma in situ (DCIS). It is typically recommended following a lumpectomy, especially if the tumour is large or has high-risk features. High-energy X-rays are employed in the treatment to locate and kill any remaining cancer cells in the breast tissue. Radiation therapy significantly decreases the possibility that DCIS could recur.
- Mammography is the most common screening method for detecting breast calcifications that may indicate ductal carcinoma in situ (DCIS).
- Breast ultrasound is often used in conjunction with mammography to evaluate areas of concern further.
- MRI: Provides high-resolution images that help determine the extent of DCIS.
- Biopsy: The best test for diagnosing DCIS is a biopsy, in which tissue is removed from the suspicious region to determine whether cancer cells are present.
MediRehab (a chain of Rehabilitation centres—part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsultations and online therapy sessions.
- Physical Therapy assists in the recovery of strength, improvement in mobility, and removal of any restrictions after surgery (e.g., mastectomy or lumpectomy).
- Lymphedema Management: Physical therapists can help reduce arm or breast swelling in patients undergoing radiation therapy or surgery.
- Depending on the severity of the condition, your healthcare professional may prescribe medicine to help control your symptoms and support the treatment plan.
Instantly Connect with our Specialists
Hospitals for Ductal Carcinoma In Situ in Singapore
Thomson Medical Centre
Singapore, Singapore
Apart from in-detail treatment procedures available, Thomson Medical Centre located in Thomson Road, Singapore has a wide variety of facilities available for International Patients. Some of the facilities which are provided by them are Accommodation, Airport Transfer, Choice of Meals, Interpreter, SIM, TV inside room. Also listed below are some of the most prominent infrastructural details:
- The bed capacity of Thomson Medical Center (of Thomson Medical Group) is 190.
- Thomson Medical Group has a prominent presence throughout Asia in Malaysia, Singapore and Indonesia.
- There is a 24/7 Outpatient Family Clinic.
- TMC also consists of various fertility clinics inclusive of an IVF clinic.
- A cancer center for breast, gynecological as well as colorectal tumors of women.
Mount Elizabeth Novena Hospital
Novena, Singapore
Mount Elizabeth Novena Hospital located in Novena, Singapore is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
- Capacity of 333 beds
- Intensive Care Unit beds
- Endoscopy beds
- Day ward with 20 beds
- 13 Operating Theatres, which includes 1 Neurological operating room, 2 Cardiac operating rooms, 4 Orthopaedic operating rooms, etc.
- High Dependency Unit (HDU)
- Neonatal Intensive Care Unit (NICU)
- 24/7 Accident & Emergency Department
- Maternity ward
- 1 major operating unit with 13 operating rooms inclusive of 1 hybrid theatre
- In-house Pharmacy
- Rooms are categorized as Single Signature Rooms, Junior Suite and Regal Suite
- All patient rooms are equipped with electric safe, LCD, sofa cum bed, wardrobe, radio channels, and much more
Parkway East Hospital
Singapore, Singapore
Parkway East Hospital located in Joo Chiat Pl, Singapore is accredited by JCI. Also listed below are some of the most prominent infrastructural details:
- Total capacity for 143 beds
- Hospital rooms are available- Single room, 2-bedded room (8), 4-bedded room (2), Deluxe room, and Orchid/Hibiscus Suite
- All rooms are equipped with all ensuite facilities like Free wifi, mini fridge, sofa couch, telephone, in-room safe, TV, etc.
- Maternity wards- Accredited as a baby-friendly hospital under the World Health Organisations Baby-Friendly Hospital Initiative (BFHI)
- 1 Neonatal Intensive Care Unit (NICU) with 14 cots
- Intensive Care Unit
- 1 Operation Theatre with 5 Operating rooms
- 1 Nursery with 30 cots
- 1 Parentcraft room
- 24-hour walk-in-clinic (for emergency)
- 24-hour Pharmacy
Our Services to better your experience
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Why Choose Singapore for Duct Carcinoma In Situ Treatment?
Singapore is an excellent destination for treating ductal carcinoma in situ (DCIS) due to its world-class medical infrastructure, highly trained medical professionals, and access to the latest technologies. The country offers comprehensive care tailored to each patient's specific needs, including radiation therapy, surgery, and targeted therapies. Singapore is also a favoured destination for high-value care because the cost of medical care is often lower compared to other countries.
Frequently Asked Questions
Yes, mammography can often detect ductal carcinoma in situ (DCIS). DCIS usually appears as microcalcifications, microscopic calcium deposits that appear as white specks on X-rays. Microcalcifications can also occur with benign conditions, but when they occur in specific patterns, they can be a marker for DCIS. Mammograms are a key early detection method for DCIS, often before symptoms develop.
In Singapore, a biopsy is the gold standard for diagnosing ductal carcinoma in situ (DCIS). While mammograms and other imaging tests can identify problematic spots, a biopsy is necessary to collect a tissue sample for microscopic analysis. Doctors can use this to effectively diagnose DCIS, evaluate its features, and choose the best course of treatment.
In Singapore, ductal carcinoma in situ (DCIS) often needs surgery, although this depends on the individual case. Based on the size, location, and other features of the DCIS, the most frequent surgical options are mastectomy (breast removal) or lumpectomy (tumour removal).
Surgery is not always needed for DCIS, especially if the issue is detected early and can be treated with hormone therapy or radiation. After consulting with the medical team, the choice is made based on the patient's condition and personal preferences.
Mastectomy can be suggested for Ductal Carcinoma In Situ (DCIS) in Singapore if the DCIS is extensive or widespread or if it occurs in several locations within the breast, so that breast-conserving surgery, such as lumpectomy, is not as effective. It can also be suggested if the patient is at high risk of recurrence or if prior surgery has not worked to remove the cancer.
Radiation therapy is often recommended in Singapore’s healthcare environments for ductal carcinoma in situ (DCIS), particularly after a lumpectomy. It targets any remaining breast cancer cells, reducing the risk of recurrence. However, radiation therapy is not required for all DCIS patients. Tumour size, margins, grade, and other risk factors affect the decision.
In Singapore patients, ductal carcinoma in situ (DCIS) may recur after treatment; the risk is low if proper treatment is undertaken. The opposite or the same breast (local recurrence) can suffer from recurrence. Several factors, including the grade of DCIS, surgical margins, radiation therapy application, and the patient's overall condition, can influence the risk of recurrence. Imaging tests, monitoring, and follow-up treatment are essential in detecting early recurrence.
Over the years, the survival rate for breast cancer has seen a significant boost due to advancements in treatment options and the ability to catch it early. For instance, patients diagnosed with Stage I breast cancer enjoy a remarkable 90% survival rate over five years. In contrast, those facing Stage II breast cancer have an 80% survival rate for the same period, as highlighted in a 2017 report from the Singapore Cancer Registry.
To find a certified cancer specialist, search MediGence’s website, which offers a list of top-class and internationally trained oncologists from Singapore's best hospitals. Through MediGence, you can search for specialists' profiles, review their credentials, experience, and ratings, and book online consultations. To receive the best care for your condition, the website also helps you find the best hospitals and provides personalised assistance tailored to your health needs.